Self-sterilizing medical devices market seen growing to $1.88 billion by 2030

A new market report projects strong growth for self-sterilizing medical devices as hospitals push harder to cut infections, improve surgical hygiene and reduce cross-contamination. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Self-sterilizing medical devices are positioned as a response to hospital-acquired infections and surgical site infection risks in clinical settings. - The market is expanding alongside pressure on healthcare systems to improve infection prevention without relying only on external sterilization workflows. - The report flags growing demand for reusable instruments, minimally invasive surgery and antimicrobial device surfaces as key adoption drivers.

What happened: - The Business Research Company released a report on the self sterilizing medical devices market on July 22, 2026. - The market was valued at $0.98 billion in 2025 and is forecast to reach $1.11 billion in 2026. - The report projects the market will reach $1.88 billion by 2030. - The report covers market size, trends and global forecasts for 2026-2035. - The report includes a free sample and the full report.

The details: - Self-sterilizing medical devices use built-in technologies to reduce or eliminate microbial contamination without external sterilization. - Common approaches include antimicrobial coatings, ultraviolet light and self-cleaning surface technologies. - The report ties historic growth to hospital-acquired infections, surgical hygiene standards, reusable instruments, hospital infrastructure growth in emerging economies and early antimicrobial coating adoption. - The forecast period is supported by self-disinfecting materials, autonomous infection prevention systems, more minimally invasive surgeries and stronger efforts to reduce cross-contamination. - The report highlights rising use of UV-C embedded sterilization in reusable instruments. - The report also points to stricter hospital infection-prevention protocols, increased regulatory requirements for validating autonomous sterilization and advances in biocompatible self-disinfecting surfaces. - The rising prevalence of hospital-acquired infections is a major demand driver. - In November 2024, the Australian Institute of Health and Welfare reported that hospital-acquired complications affected 115,000 public hospitalizations and 34,200 private hospitalizations in Australia during 2022-23. - Healthcare-associated infections accounted for 37% of those complications. - The growing number of surgical procedures is another market catalyst. - Intuitive Surgical said in its 2024 annual report that about 2,683,000 surgeries were performed using da Vinci systems in early 2024, up from 2,286,000 in 2023 and 1,875,000 in 2022. - Rising healthcare spending is also supporting adoption. - The Centers for Medicare and Medicaid Services said US healthcare expenditures rose 7.5% in 2023 to $4.9 trillion, or about $14,570 per person. - North America held the largest regional share in 2025. - Asia-Pacific is expected to post the fastest growth rate during the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The report suggests infection control is shifting from a cleaning-and-reprocessing problem to a device-design problem. - The focus on validation requirements and biocompatible surfaces points to a market where regulation may shape adoption as much as technology. - The strong growth forecast implies buyers are willing to pay for infection-prevention features that can reduce downstream clinical risk and operating-room disruption.

What's next: - Adoption may accelerate as hospitals face tighter infection-control expectations and more robotic or minimally invasive procedures. - Market competition is likely to intensify around coatings, UV-C integration and autonomous sterilization validation. - Regional growth outside North America could widen as healthcare infrastructure improves in developing markets.

The bottom line: - Self-sterilizing medical devices are moving from niche infection-control tools toward a broader market opportunity tied to patient safety, procedure growth and higher healthcare spending.